Therapeutic Products

Biosimilar Antibodies in Pipeline

The popularity of biosimilar products is growing in the emerging markets as well as in developed countries. Substituting lower-cost biosimilars for branded biologics would help the patients who cannot afford the high cost of innovator drugs. Keeping this in mind, IMGENEX India is developing many biosimilars as listed in the following table. In future, other products will be added to this growing list of biosimilars.